 |
|
|
| |
Molnupiravir and Nirmatrelvir/ritonavir effectiveness in reducing the risk for COVID-19 disease progression and death
|
| |
| |
ID Week 2023 oct 14
D. Paraskevis1,2, M. Gkova2, K. Mellou2, K. Gkolfinopoulou2, E.G. Kostaki1, S. Loukides3, A. Kotanidou4, A. Skoutelis5, E. Thiraios6, G.
Saroglou7, D. Zografopoulos8, E. Mossialos9,10, T. Zaoutis2,11, M. Gaga12, A. Antoniadou13, 14*, S. Tsiodras2,13*
|
| |
|
|
|
|
|
